These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 24338950

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE, Shin JS, Leem DG, Kim SD, Cho WJ, Lee KT.
    Chem Biol Interact; 2016 Dec 25; 260():196-207. PubMed ID: 27720946
    [Abstract] [Full Text] [Related]

  • 23. Honokiol inhibits melanoma stem cells by targeting notch signaling.
    Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM.
    Mol Carcinog; 2015 Dec 25; 54(12):1710-21. PubMed ID: 25491779
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 26. A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant ARF876L nuclear import and function.
    Wu Z, Wang K, Yang Z, Pascal LE, Nelson JB, Takubo K, Wipf P, Wang Z.
    Prostate; 2020 Mar 15; 80(4):319-328. PubMed ID: 31868960
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.
    Zhang Y, Shaik AA, Xing C, Chai Y, Li L, Zhang J, Zhang W, Kim SH, Lü J, Jiang C.
    Invest New Drugs; 2012 Oct 15; 30(5):1820-9. PubMed ID: 21870073
    [Abstract] [Full Text] [Related]

  • 29. BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells.
    Liu RX, Ren WY, Ma Y, Liao YP, Wang H, Zhu JH, Jiang HT, Wu K, He BC, Sun WJ.
    Int J Oncol; 2017 Sep 15; 51(3):907-917. PubMed ID: 28731124
    [Abstract] [Full Text] [Related]

  • 30. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J, Xie B, Capodice JL, Katz AE.
    Prostate; 2012 Feb 15; 72(3):244-52. PubMed ID: 21656835
    [Abstract] [Full Text] [Related]

  • 31. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
    Chae JI, Jeon YJ, Shim JH.
    Oncol Rep; 2013 Jun 15; 29(6):2318-24. PubMed ID: 23525508
    [Abstract] [Full Text] [Related]

  • 32. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
    Hahm ER, Singh SV.
    Mol Cancer Ther; 2007 Oct 15; 6(10):2686-95. PubMed ID: 17938262
    [Abstract] [Full Text] [Related]

  • 33. Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells.
    Wu W, Karelia D, Pramanik K, Amin SG, Sharma AK, Jiang C, Lu J.
    Mol Carcinog; 2018 Aug 15; 57(8):1055-1066. PubMed ID: 29668110
    [Abstract] [Full Text] [Related]

  • 34. PSA regulates androgen receptor expression in prostate cancer cells.
    Saxena P, Trerotola M, Wang T, Li J, Sayeed A, Vanoudenhove J, Adams DS, Fitzgerald TJ, Altieri DC, Languino LR.
    Prostate; 2012 May 15; 72(7):769-76. PubMed ID: 21956655
    [Abstract] [Full Text] [Related]

  • 35. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells.
    Khurana N, Talwar S, Chandra PK, Sharma P, Abdel-Mageed AB, Mondal D, Sikka SC.
    Int J Oncol; 2016 Oct 15; 49(4):1609-19. PubMed ID: 27499349
    [Abstract] [Full Text] [Related]

  • 36. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
    Zhang BY, Li YF, Lai Y, Li YS, Chen ZJ.
    Zhongguo Zhong Yao Za Zhi; 2015 Mar 15; 40(5):950-6. PubMed ID: 26087562
    [Abstract] [Full Text] [Related]

  • 37. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X, Choi RY, Jawad SM, Arnold JT.
    Prostate; 2011 May 15; 71(7):766-77. PubMed ID: 21031436
    [Abstract] [Full Text] [Related]

  • 38. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
    Zhang Y, Won SH, Jiang C, Lee HJ, Jeong SJ, Lee EO, Zhang J, Ye M, Kim SH, Lü J.
    Pharm Res; 2012 Jun 15; 29(6):1595-608. PubMed ID: 22281759
    [Abstract] [Full Text] [Related]

  • 39. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth.
    Liu S, Yuan Y, Okumura Y, Shinkai N, Yamauchi H.
    Biochem Biophys Res Commun; 2010 Apr 02; 394(2):297-302. PubMed ID: 20206136
    [Abstract] [Full Text] [Related]

  • 40. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y, Ikezoe T, Takeuchi T, Adachi Y, Ohtsuki Y, Koeffler HP, Taguchi H.
    Oncol Rep; 2006 Jun 02; 15(6):1581-90. PubMed ID: 16685399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.